Table 2 Methylation status of Zp and Rp in EBV-associated cell lines and tumors
EBV-associated cell lines and tumors | Zp methylation status (Methylated CpG sites, %) | Rp methylation status (methylated CpG sites, %) |
|---|---|---|
Cell lines | Â | Â |
Akata | 67% | 59% |
B95-8 | 17% | 36% |
C666-1 | 75% | 99% |
Namalwa | 46% | 53% |
Raji | 60% | 87% |
Rael | 67% | 83% |
Wan | 18% | 29% |
Nude mice-passaged tumors | Â | Â |
C15 | 68% | 96% |
C18 | 56% | 59% |
Tumors | Â | Â |
NPC | Â | Â |
NPC1 | 58% | 97% |
NPC2 | 92% | 88% |
NPC12 | 70% | 87% |
BL | Â | Â |
BL3 | 62% | 80% |
BL5 | 53% | 82% |
BL10 | 67% | 82% |
PTLD | Â | Â |
PTLD2 | 32% | 64% |
PTLD4a | 44% | 85% |
PTLD8 | 22% | 70% |
PTLD10 | 47% | 73% |
PTLD19 | 53% | 80% |
PTLD20 | 75% | 80% |